Literature DB >> 16866857

Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.

D Vallböhmer1, S R DeMeester, J H Peters, D S Oh, H Kuramochi, D Shimizu, J A Hagen, K D Danenberg, P V Danenberg, T R DeMeester, P T Chandrasoma.   

Abstract

The molecular pathogenesis of Barrett's esophagus is poorly understood. Evidence suggests that at a phenotypic level, the metaplastic process begins with the transformation of squamous epithelium in the distal esophagus to cardiac mucosa, which subsequently becomes intestinalized. The homeobox gene Cdx-2 has been shown to be an important transcriptional regulator of embryonic differentiation and maintenance of adult intestinal type epithelium. We hypothesized that Cdx-2 gene expression levels increase with the phenotypic transformation of normal squamous mucosa to the intestinalized columnar mucosa of Barrett's esophagus. Endoscopic biopsies were obtained at the gastroesophageal junction in patients with symptoms of gastroesophageal reflux disease and classified according to histology: normal squamous mucosa (n = 62), cardiac mucosa (n = 19), oxynto-cardiac mucosa (n = 14), and intestinal metaplasia (n = 15). Duodenal biopsies (n = 26) served as the columnar control. After laser capture microdissection and RNA isolation, gene expression levels of Cdx-2 were measured in each tissue type by quantitative reverse transcription polymerase chain reaction. Consistent with its known function, Cdx-2 gene expression levels were highest in duodenal mucosa and nearly absent in squamous epithelium. There was a stepwise increase in Cdx-2 gene expression from cardiac to Barrett's epithelium (P < 0.001). Expression levels of Cdx-2 in cardiac and oxynto-cardiac mucosa were 40-70 times higher and Barrett's mucosa 400 times higher than that found in squamous epithelium. Relative expression of the homeobox gene Cdx-2, known to induce differentiation of intestinal type epithelium, increases in a stepwise fashion during the phenotypic transformation of distal esophageal squamous mucosa to cardiac columnar mucosa and to the intestinalized columnar mucosa of Barrett's esophagus. Therefore, Cdx-2 may be a potential biomarker to detect the early transition to Barrett's esophagus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16866857     DOI: 10.1111/j.1442-2050.2006.00586.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  25 in total

1.  Activation of the BMP4 pathway and early expression of CDX2 characterize non-specialized columnar metaplasia in a human model of Barrett's esophagus.

Authors:  Daniel Castillo; Sonia Puig; Mar Iglesias; Agustín Seoane; Carme de Bolós; Vicente Munitiz; Pascual Parrilla; Laura Comerma; Richard Poulsom; Kausilia K Krishnadath; Luís Grande; Manuel Pera
Journal:  J Gastrointest Surg       Date:  2011-11-11       Impact factor: 3.452

2.  A surprise cell of origin for Barrett's esophagus.

Authors:  Urs von Holzen; Greg H Enders
Journal:  Cancer Biol Ther       Date:  2012-06-01       Impact factor: 4.742

3.  Histopathology of columnar-lined esophagus in patients with gastroesophageal reflux disease.

Authors:  Johannes Lenglinger; Claudia Ringhofer; Margit Eisler; Roland Sedivy; Fritz Wrba; Johannes Zacherl; Enrico P Cosentini; Gerhard Prager; Michael Haefner; Martin Riegler
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

4.  Videoendoscopy and histopathology of the esophagogastric junction in patients with gastroesophageal reflux disease.

Authors:  Claudia Ringhofer; Johannes Lenglinger; Margit Eisler; Fritz Wrba; Roland Sedivy; Johannes Zacherl; Enrico P Cosentini; Gerhard Prager; Elena Devyatko; Martin Riegler
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

5.  Towards the molecular characterization of disease: comparison of molecular and histological analysis of esophageal epithelia.

Authors:  Daniel Vallböhmer; Paul Marjoram; Hidekazu Kuramochi; Daisuke Shimizu; Hsuan Jung; Steve R DeMeester; Daniel Oh; Parakrama T Chandrasoma; Kathleen D Danenberg; Tom R DeMeester; Peter V Danenberg; Jeffrey H Peters
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

6.  Aspirin prevents NF-κB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.

Authors:  Xiaofang Huo; Xi Zhang; Chunhua Yu; Edaire Cheng; Qiuyang Zhang; Kerry B Dunbar; Thai H Pham; John P Lynch; David H Wang; Robert S Bresalier; Stuart J Spechler; Rhonda F Souza
Journal:  Gut       Date:  2017-04-25       Impact factor: 23.059

7.  The columnar-lined mucosa at the gastroesophageal junction in non-human primates.

Authors:  Carlos A Rubio; Edward J Dick; Natalia E Schlabritz-Loutsevitch; Abiel Orrego; Gene B Hubbard
Journal:  Int J Clin Exp Pathol       Date:  2008-01-20

8.  Bile acid alone, or in combination with acid, induces CDX2 expression through activation of the epidermal growth factor receptor (EGFR).

Authors:  Nelly E Avissar; Liana Toia; Yingchuan Hu; Thomas J Watson; Carolyn Jones; Daniel P Raymond; Alexi Matousek; Jeffrey H Peters
Journal:  J Gastrointest Surg       Date:  2008-10-15       Impact factor: 3.452

9.  Inhibition of nucleostemin upregulates CDX2 expression in HT29 cells in response to bile acid exposure: implications in the pathogenesis of Barrett's esophagus.

Authors:  Yong-Gang Sun; Xing-Wei Wang; Shi-Ming Yang; Gang Zhou; Wei-Qiang Wang; Hong-Bin Wang; Rong-Quan Wang; Dian-Chun Fang
Journal:  J Gastrointest Surg       Date:  2009-05-16       Impact factor: 3.452

10.  Pathogenesis of Barrett's esophagus: bile acids inhibit the Notch signaling pathway with induction of CDX2 gene expression in human esophageal cells.

Authors:  David J Morrow; Nelly E Avissar; Liana Toia; Eileen M Redmond; Thomas J Watson; Carolyn Jones; Dan P Raymond; Virginia Litle; Jeffrey H Peters
Journal:  Surgery       Date:  2009-10       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.